Pharmafile Logo
Pharmafocus logo
Advanced Search

Cancer

Showing 15 posts of 1067 posts found.

Breakthrough Breast Cancer's senior policy manager Caitlin Palframan image

Charity ‘deeply concerned’ on CDF changes

November 13, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, breakthrough breast cancer, palframan

A leading cancer charity has warned that a number of key drugs are at risk of being withdrawn from patients …

News
Welsh Assembly image

Wales Assembly facing questions over cancer

November 5, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, Wales, Welsh, assembly, drugs fund, oncology

The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …

News
Iressa image

Retrospective study backs Iressa use in oesophageal cancer

November 5, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Cancer Oesophagus Gefitinib, Iressa, gefitinib, oncology

A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …

News
BMS image

BMS lung cancer drug scores in Phase II

October 31, 2014
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, NSCLC, bristol myers-squibb, odivo

Bristol-Myers Squibb is still in the hunt to gain significant market share in the PD-1 therapeutic vaccine race after releasing …

News
Caner image

More cancer patients surviving for longer

October 31, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, bladder, breast, myeloma, oncology, ons, prostate

Cancer survival rates in England are continuing to improve, though many cancers still have an ‘extremely poor’ prognosis, according to …

News
nhs_parliament_2_8

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

News
prof_paul_workman

Cancer drug discovery system ‘broken’

October 24, 2014
Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …

News
Roche image

Roche and Pharmacyclics agree leukaemia pact

October 17, 2014
Research and Development, Sales and Marketing BMS, CLL, Cancer, Gazyva, Pharmacyclics, Roche, imbruvica, leukaemia

Pharmacyclics’s cancer drug Imbruvica will be tested in combination with Roche’s Gazyva in a new partnership announced by the firms. …

News
Roche image

New cancer drugs escalate Roche earnings

October 16, 2014
Research and Development, Sales and Marketing Cancer, Herceptin (trastuzumab), Kadcyla, Perjeta, Q3, Roche, ado-trastuzumab emtansine, pertuzumab

Roche’s sales saw solid growth in the first nine months of the year, increased by the firm’s new cancer medicines. …

News
Reverse the odds image

Charity launches second cancer research game

October 9, 2014
Medical Communications, Sales and Marketing CRUK, Cancer, amazon, genes in space, oncology, play, reverse the odds

Cancer Research UK has launched its second citizen science game this year called ‘Reverse The Odds’ in an attempt to …

News

NHS England consults on Cancer Drugs Fund

October 6, 2014
Research and Development, Sales and Marketing CDF, Cancer, NHS, NHS England, commissioning, oncology

NHS England is declaring new changes to the way the Cancer Drugs Fund operates in order to plug a major …

News
BMS image

BMS therapeutic cancer vaccine given swift FDA appraisal

September 29, 2014
Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, FDA, Vaccine, bristol myers-squibb, keytruda, melanoma, opdivo

Bristol-Myers Squibb has been granted a speedy review for its new cancer immunotherapy drug Opdivo by the FDA for patients …

News
Roche image

Roche’s Perjeta sees ‘impressive’ survival rates

September 29, 2014
Sales and Marketing Cancer, ESMO, Perjeta, Roche, breast, madrid

Roche’s oncology drug Perjeta combined with other medicines can help certain breast cancer patients live longer. This is according to …

News
MedImmune image

MedImmune and CRUK team up on cancer

September 25, 2014
Sales and Marketing AstraZeneca, CRT, CRUK, Cambridge, Cancer, MedImmune

AstraZeneca’s biologics arm MedImmune has joined forces with Cancer Research UK to establish a new research laboratory in Cambridge, UK. …

News
Cancer cells image

Half of cancers diagnosed at late stage

September 22, 2014
Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, oncology

A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026